Abstract Background: Glycolipid Metabolic Disorders (GLMD) are characterized by imbalances in glucose and lipid homeostasis, often presenting with severe clinical symptoms. Current pharmacotherapies such as orlistat and metformin show clear efficacy but are associated with long-term tolerability concerns. This study aimed to evaluate whether the next-generation probiotic candidate Phocaeicola dorei YGMCC0564 attenuates HFD-induced glycolipid metabolic disturbances in mice.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Qiuxiang
Contact Qiuxiang, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack